Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GILD
PFE
Add up to 3 more stocks
GILD
Gilead Sciences, Inc.
-0.75%
$143.72-1.09Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$178.44B
52W Range
$108.46 - $157.29
PFE
Pfizer Inc.
+0.25%
$27.72+0.07Delayed quote: Sep 11, 2026, 4:01 PM EDT
Market Cap
$157.99B
52W Range
$23.58 - $29.21
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 36.63 |
| Forward P/E | N/A | 9.32 |
| P/B Ratio | 15.09 | 1.85 |
| P/S Ratio | 5.86 | 2.48 |
| P/FCF Ratio | 13.76 | 14.38 |
| EV/EBITDA | N/A | 10.15 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.6% | 71.3% |
| Operating Margin | 39.7% | 25.1% |
| Net Margin | -10.6% | 6.8% |
| ROE | -27.4% | 5.1% |
| ROA | -6.6% | 2.2% |
| ROIC | -3.7% | 9.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.27 | 1.27 |
| Quick Ratio | 1.09 | 0.96 |
| Debt/Equity | 2.22 | 0.74 |
| Interest Coverage | 11.43 | 5.78 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.2% | 6.2% |
| Payout Ratio | N/A | 227.3% |
| Yrs of Dividend Growth | 10 | 16 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.